Waregem (Belgium) / Rotterdam (The Netherlands)[1], 23 December 2010 – Arseus announces today that it has signed a definitive agreement for the acquisition of the Belgian company Devroe Instruments (Devroe), a leading player on the Belgian market for surgical instruments, endoscopy services and solutions for sterilization handling. In 2010 Devroe expects to realize a turnover of approximately € 3 million and a double-digit EBITDA margin.
Mario Huyghe, CEO of Arseus Medical: “The acquisition of Devroe is fully in line with Arseus Medicals’ growth strategy for surgery and sterilization. Since the beginning of this year, Arseus Medical has been further developing its renewed S2S (Surgery to Sterilization) concept. This solution for surgery and sterilization departments in hospitals is aimed at improving the efficiency, traceability and quality of instrument and implant management. The S2S solution of Arseus Medical consists of surgical instruments, fixation solutions with instrument identification as well as sterilization infrastructure and services.
With the acquisition of Devroe, Arseus Medical is strengthening its position and product offering in surgery and sterilization in the Benelux countries. With its exclusive distributions of quality instruments (Medicon, Nopa, Geister, Ackermann, Hipp) and Devroe’s own OMF system, as well as the introduction of new fixation concepts and customer-specific services for mapping, repair and traceability of surgical instruments, Devroe is strategically complementary to Arseus Medical.”
Xavier Deklerck, Business Manager of Devroe Instruments: “Integrating the activities of Devroe Instruments with Arseus Medical will provide our customers with a significantly expanded portfolio of high-quality A-brands in the surgery field. In addition, both companies will combine their specific knowledge and translate this into new solutions and services for surgery and sterilization.”
[1] This press release was sent out by Arseus NV and Arseus BV.
Please open the link below for the full press release: